Hepatitis C virus antibody seroconversion in a volunteer blood donor
β Scribed by C. A. Hyland; L. Mison; D. DeLeacy; I. F. Young
- Book ID
- 114439874
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 219 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0372-1248
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The results of hepatitis C virus (HCV) antibody test of 237, 813 blood donations collected from 143, 815 donors by the West Midlands Blood Transfusion Centre in 1993 were analyzed retrospectively in order to determine the seroconversion rate among established previously antiβHCV negativ
Recently a recombinant polypeptide of hepatitis C virus (HCV) has been developed by the Chiton Corporation in California. This antigen has been used to develop an ELISA test (Ortho Diagnostic Systems for serum anti-HCV antibodies. Preliminary data have shown that this virus is the major cause of NAN
Approximately 90% of subjects with chronic hepatitis resulting from hepatitis C virus infection have hepatitis C virus RNA in serum. However, the prevalence of hepatitis C virus RNA in serum from subjects with hepatitis C virus antibody associated with persistent normal liver biochemical values is u
## Abstract Of 103,203 donations collected in Scotland and Northern Ireland over a 3βmonth period and screened for HCV antibody by Ortho or Abbott secondβgeneration ELISAs, 340 were found repeatedly reactive. Supplementary testing with RIBAβ2 resulted in 77 being classified as positive, 130 as inde